148 related articles for article (PubMed ID: 8558128)
1. Assessment of antigenicity and genetic variation of glycoprotein B of murine cytomegalovirus.
Xu J; Lyons PA; Carter MD; Booth TW; Davis-Poynter NJ; Shellam GR; Scalzo AA
J Gen Virol; 1996 Jan; 77 ( Pt 1)():49-59. PubMed ID: 8558128
[TBL] [Abstract][Full Text] [Related]
2. Expression of the glycoprotein H of murine cytomegalovirus and identification of an N-terminal antibody-binding region.
Xu J; Scalzo AA; Lyons PA; Shellam GR
Virology; 1994 Oct; 204(1):466-70. PubMed ID: 7522376
[TBL] [Abstract][Full Text] [Related]
3. Effect of natural sequence variation at the H-2Ld-restricted CD8+ T cell epitope of the murine cytomegalovirus ie1-encoded pp89 on T cell recognition.
Lyons PA; Allan JE; Carrello C; Shellam GR; Scalzo AA
J Gen Virol; 1996 Oct; 77 ( Pt 10)():2615-23. PubMed ID: 8887498
[TBL] [Abstract][Full Text] [Related]
4. Identification, sequencing and expression of the glycoprotein L gene of murine cytomegalovirus.
Xu J; Scalzo AA; Lyons PA; Farrell HE; Rawlinson WD; Shellam GR
J Gen Virol; 1994 Nov; 75 ( Pt 11)():3235-40. PubMed ID: 7964634
[TBL] [Abstract][Full Text] [Related]
5. Cloning, characterization, and expression of the murine cytomegalovirus homologue of the human cytomegalovirus 28-kDa matrix phosphoprotein (UL99).
Cranmer LD; Clark C; Spector DH
Virology; 1994 Dec; 205(2):417-29. PubMed ID: 7975245
[TBL] [Abstract][Full Text] [Related]
6. DNA sequence and transcriptional analysis of the glycoprotein M gene of murine cytomegalovirus.
Scalzo AA; Forbes CA; Davis-Poynter NJ; Farrell HE; Lyons PA
J Gen Virol; 1995 Nov; 76 ( Pt 11)():2895-901. PubMed ID: 7595401
[TBL] [Abstract][Full Text] [Related]
7. Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures.
Schoppel K; Hassfurther E; Britt W; Ohlin M; Borrebaeck CA; Mach M
Virology; 1996 Feb; 216(1):133-45. PubMed ID: 8614980
[TBL] [Abstract][Full Text] [Related]
8. Identification of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant vaccinia virus.
Rapp M; Messerle M; Bühler B; Tannheimer M; Keil GM; Koszinowski UH
J Virol; 1992 Jul; 66(7):4399-406. PubMed ID: 1318410
[TBL] [Abstract][Full Text] [Related]
9. High-frequency interferon-gamma-secreting splenocytes specific for murine cytomegalovirus immediate-early-1 (IE-1) peptide 168YPHFMPTNL176 are insufficient to provide complete protection from viral challenge.
Morley PJ; Ertl PF; Sweet C
J Med Virol; 2003 Feb; 69(2):240-50. PubMed ID: 12683414
[TBL] [Abstract][Full Text] [Related]
10. Characterization of glycoprotein B of the gammaherpesvirus equine herpesvirus-2.
Holloway SA; Studdert MJ; Drummer HE
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1619-29. PubMed ID: 9680123
[TBL] [Abstract][Full Text] [Related]
11. Expression of the murine cytomegalovirus glycoprotein H by recombinant vaccinia virus.
Rapp M; Lucin P; Messerle M; Loh LC; Koszinowski UH
J Gen Virol; 1994 Jan; 75 ( Pt 1)():183-8. PubMed ID: 8113726
[TBL] [Abstract][Full Text] [Related]
12. Binding of neutralizing monoclonal antibodies to regions of the fusion protein of respiratory syncytial virus expressed in Escherichia coli.
Lounsbach GR; Bourgeois C; West WH; Robinson JW; Carter MJ; Toms GL
J Gen Virol; 1993 Dec; 74 ( Pt 12)():2559-65. PubMed ID: 7506297
[TBL] [Abstract][Full Text] [Related]
13. Development of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replication.
Morello CS; Ye M; Spector DH
J Virol; 2002 May; 76(10):4822-35. PubMed ID: 11967299
[TBL] [Abstract][Full Text] [Related]
14. Intranasal immunization with recombinant vesicular stomatitis virus expressing murine cytomegalovirus glycoprotein B induces humoral and cellular immunity.
Wilson SR; Wilson JH; Buonocore L; Palin A; Rose JK; Reuter JD
Comp Med; 2008 Apr; 58(2):129-39. PubMed ID: 18524170
[TBL] [Abstract][Full Text] [Related]
15. Generation of monoclonal antibodies directed against the immunogenic glycoprotein K8.1 of human herpesvirus 8.
Lang D; Birkmann A; Neipel F; Hinderer W; Rothe M; Ernst M; Sonneborn HH
Hybridoma; 2000 Aug; 19(4):287-95. PubMed ID: 11001401
[TBL] [Abstract][Full Text] [Related]
16. Systemic priming-boosting immunization with a trivalent plasmid DNA and inactivated murine cytomegalovirus (MCMV) vaccine provides long-term protection against viral replication following systemic or mucosal MCMV challenge.
Morello CS; Ye M; Hung S; Kelley LA; Spector DH
J Virol; 2005 Jan; 79(1):159-75. PubMed ID: 15596812
[TBL] [Abstract][Full Text] [Related]
17. Common epitopes of glycoprotein B map within the major DNA-binding proteins of bovine herpesvirus type 2 (BHV-2) and herpes simplex virus type 1 (HSV-1).
Hammerschmidt W; Conraths F; Mankertz J; Buhk HJ; Pauli G; Ludwig H
Virology; 1988 Aug; 165(2):406-18. PubMed ID: 2457278
[TBL] [Abstract][Full Text] [Related]
18. Detection of murine cytomegalovirus (MCMV) DNA in skin using the polymerase chain reaction (PCR).
Abecassis MM; Jiang X; O'Neil ME; Bale JF
Microb Pathog; 1993 Jul; 15(1):17-22. PubMed ID: 8412624
[TBL] [Abstract][Full Text] [Related]
19. Cloning and characterization of the guinea pig cytomegalovirus glycoprotein B gene.
Schleiss MR
Virology; 1994 Jul; 202(1):173-85. PubMed ID: 8009831
[TBL] [Abstract][Full Text] [Related]
20. Virus neutralizing activity induced by synthetic peptides of glycoprotein D of herpes simplex virus type 1, selected by their reactivity with hyperimmune sera from mice.
Geerligs HJ; Kocken CH; Drijfhout JW; Weijer WJ; Bloemhoff W; Wilterdink JB; Welling GW; Welling-Wester S
J Gen Virol; 1990 Aug; 71 ( Pt 8)():1767-74. PubMed ID: 2167930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
